SVP, General Counsel at Keros Therapeutics, Inc., filing insider transactions on 2026-02-18.
Total Purchases
—
0 transactions
Total Sales
$78K
1 transaction
Companies Traded
1
1 total filings
Active Since
2026-02-18
Last: 2026-02-18
Other Reporting Insiders at Keros Therapeutics, Inc.
Transaction History
| Date | Ticker | Type | Shares | Price | Value | Owned After | |
|---|
| 2026-02-18 | KROS | Sale | 4,745 | $16.35 | $78K | 39.8K | SEC ↗ |
Director & CHIEF EXECUTIVE OFFICER